DLTR
34
-4
ZTS
47
2
PNW
66
3
AIG
38
-4
DOV
61
-2
HCP
58
4
CINF
47
2
MCO
73
3
XEL
67
2
UHS
54
3
AMP
69
-3
TGNA
53
2
CSX
51
-2
A
36
2
MAS
51
4
CVX
46
5
NI
75
2
DE
46
3
SRE
63
-3
DG
2
-6
DLTR
34
-4
ZTS
47
2
PNW
66
3
AIG
38
-4
DOV
61
-2
HCP
58
4
CINF
47
2
MCO
73
3
XEL
67
2
UHS
54
3
AMP
69
-3
TGNA
53
2
CSX
51
-2
A
36
2
MAS
51
4
CVX
46
5
NI
75
2
DE
46
3
SRE
63
-3
DG
2
-6
Financhill
Back

Alnylam Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
247.73
Seasonality Move:
10.85%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Alnylam Pharmaceuticals Price Quote

$247.73
-1.06 (-0.43%)
(Updated: November 21, 2024 at 10:15 AM ET)

Alnylam Pharmaceuticals Key Stats

Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell
Day range:
$234.43 - $249.10
52-week range:
$141.98 - $304.39
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14.06
P/B ratio:
925.96%
Volume:
1M
Avg. volume:
948.6K
1-year change:
50.54%
Market cap:
$30B
Revenue:
$1.8B
EPS:
$-2.62

How Much Does Alnylam Pharmaceuticals Make?

Is Alnylam Pharmaceuticals Growing As A Company?

Alnylam Pharmaceuticals Stock Price Performance

What Is Alnylam Pharmaceuticals 52-Week High & Low?

Alnylam Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Alnylam Pharmaceuticals?

Is Alnylam Pharmaceuticals Cash Flow Positive?

  • What Is ALNY Cash Flow From Operations?
    Cash flow from operations (TTM) is $56.6M
  • What Is Alnylam Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $302.4M
  • What Is Alnylam Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$304.6M

Alnylam Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ALNY return on invested capital is -36.66%
  • What Is Alnylam Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -8.43%
  • What Is ALNY Return On Equity?
    ROE is a measure of profitability and is 0%

Alnylam Pharmaceuticals Earnings Date & Stock Price

Alnylam Pharmaceuticals Competitors

Alnylam Pharmaceuticals Dividend Yield

Alnylam Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.71%
Revenue: -33.26% -4.95%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 7
Sell Recommendations: 1
Price Target: 301.40
Upside from Last Price: 21.15%

Major Shareholders

  • How many ALNY shares are owned by institutional investors?
    251.4M ALNY shares are owned by institutional investors
  • How many ALNY shares are owned by insiders?
    534.6K ALNY shares are owned by insiders